APTEVO THERAPEUTICS INC (APVO)

US03835L3069 - Common Stock

0.7061  +0.03 (+3.84%)

After market: 0.7 -0.01 (-0.86%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.003.11M12.29M4.31M0.00
Cost Of Goods
N/AN/AN/AN/AN/A
Gross Profit
N/AN/AN/AN/AN/A
Operating Expenses
28.88M31.75M33.69M31.81M40.96M
Research and Development
17.11M17.88M18.99M17.85M24.76M
Selling, General, and Administrative Expenses
11.77M13.87M14.70M13.95M16.20M
Operating Income
-28.88M-28.64M-21.40M-27.50M-40.96M
Other Income/Expense
578.00K-1.53M-8.01M-1.33M-2.10M
Non Recurring Items
0.0037.18M0.00-2.10M0.00
Income Before Taxes
-18.65M7.01M-29.41M-30.92M-43.06M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-17.41M8.03M-28.46M-17.75M-40.45M
EBITDA
-28.31M-27.74M-20.26M-26.09M-38.72M
 
Per Share Data
EPS Diluted Total Ops
-62.611.57-6.06-5.23-13.85
Non GAAP EPS
-81.891.58-6.09-8.96-15.96
 
Statistics
Gross Profit Margin
N/AN/AN/AN/AN/A
Profit Margin
N/A258.20%-231.57%-411.83%N/A
Operating Profit Margin
N/A-920.90%-174.13%-638.05%N/A

All data in USD

Charts